Tobias Hartmann, AD/PD 2021: Post-hoc Analysis of the LipiDiDiet Trial
touchNEUROLOGY had the pleasure of meeting with Tobias Hartmann (Director and Professor of Experimental Neurology, DIDP, Saarland University, Saarbrücken, Germany) to discuss the recent post-hoc analysis of the LipiDiDiet trial data.
Part 1 of our discussion can be found here.
The abstract entitled ‘ADCOMS: A Post-Hoc Analysis Using Data from the 3-Year Lipididiet Trial in Prodromal Alzheimer’s Disease’ was presented at The 15th International Conference for Alzheimer’s & Parkinson’s Diseases (Virtual), March 8-14, 2021.
Questions:
- Could you tell us a little about the LipiDiDiet study and its findings? (0:17)
- What were the aims of your recent post-hoc analysis of the LipiDiDiet trial data? (2:04)
- What has this analysis taught us and what is the clinical significance of these findings? (6:49)
Disclosures: Tobias Hartmann is the Coordinator of LipiDiDiet study; and received a grant for the EU Joint Programme– Neurodegenerative Disease Research (JPND) EURO‐FINGERS.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AD/PD Virtual 2021.
